Global microRNA expression profiling: Curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells

Molecular Vision

Volumn 19, Issue , 2013, Pages 544-560

  Howell, Jennifer C ^a   Chun, Eugene ^a   Farrell, Annie N ^a   Hur, Elizabeth Y ^a   Caroti, Courtney M ^a   Iuvone, P Michael ^a   Haque, Rashidul ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIOXIDANT; CURCUMIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; VASCULOTROPIN;

ARTICLE; CELL ASSAY; CELL VIABILITY; CELLULAR STRESS RESPONSE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETIC REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CATALASE; CELL LINE; CELL SURVIVAL; CLUSTER ANALYSIS; CURCUMIN; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MICRORNAS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 2; RETINAL PIGMENT EPITHELIUM; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875316940     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Tate DJ Jr, Miceli MV, Newsome DA. Phagocytosis and H2O2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1995; 36:1271-129. [PMID: 7775104].
2. Weigel AL, Handa JT, Hjelmeland LM. Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med 2002; 33:1419-1432. [PMID: 12419474].
3. Vandenbroucke K, Robbens S, Vandepoele K, Inze D, Van de Peer Y, Van Breusegem F. Hydrogen peroxide-induced gene expression across kingdoms: a comparative analysis. Mol Biol Evol 2008; 25:507-516. [PMID: 1818756 0].
4. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87:179-183. [PMID: 10926866].
5. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 2008; 7:464-473. [PMID: 18347134].
6. Mukhopadhyay P, Mukherjee S, Ahsan K, Bagchi A, Pacher P, Das DK. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS ONE 2010; 5:e15705[PMID: 21203465].
7. Woo JM, Shin DY, Lee SJ, Joe Y, Zheng M, Yim JH, Callaway Z, Chung HT. Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Mol Vis 2012; 18:901-908. [PMID: 22539869].
8. Liu JH, Wann H, Chen MM, Pan WH, Chen YC, Liu CM, Yeh MY, Tsai SK, Young MS, Chuang HY, Chao FP, Chao HM. Baicalein significantly protects human retinal pigment epithelium cells against H(2)O(2)-induced oxidative stress by scavenging reactive oxygen species and downregulating the expression of matrix metalloproteinase-9 and vascular endothelial growth factor. J Ocul Pharmacol Ther 2010; 26:421-429. [PMID: 20879805].
9. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010; 103:1545-1557. [PMID: 20100380].
10. Strasser EM, Wessner B, Manhart N, Roth E. The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells. Biochem Pharmacol 2005; 70:552-559. [PMID: 16002051].
11. Osawa T, Kato Y. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 2005; 1043:440-451. [PMID: 16037265].
12. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002; 98:234-240. [PMID: 11857414].
13. Sarkar FH, Li Y. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 2004; 555:53-64. [PMID: 15 476 851].
14. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R, Haqq C. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006; 5:24[PMID: 16784538].
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods 2001; 25:402-408. [PMID: 11846609].
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275. [PMID: 149 0 7713].
17. Haque R, Chun E, Howell JC, Sengupta T, Chen D, Kim H. MicroRNA-30b-Mediated Regulation of Catalase Expression in Human ARPE-19 Cells. PLoS ONE 2012; 7:e42542[PMID: 22880027].
18. D'Incalci M, Steward W P, Gescher AJ. Use of cancer chemo-preventive phytochemicals as antineoplastic agents. Lancet Oncol 2005; 6:899-904. [PMID: 16257798].
19. Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 2007; 4:8[PMID: 17437639].
20. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297. [PMID: 14744438].
21. Harfe BD. MicroRNAs in vertebrate development. Curr OpinGenet Dev 2005; 15:410-415. [PMID: 15979303].
22. Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006; 22:165-173. [PMID: 16 4 46010].
23. Li SC, Tang P, Lin WC. Intronic microRNA: discovery and biological implications. DNA Cell Biol 2007; 26:195-207. [PMID: 174 65886].
24. Zhang J, Du Y, Wu C, Ren X, Ti X, Shi J, Zhao F, Yin H. Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol Rep 2010; 24:1217-1223. [PMID: 20 8 78113].
25. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 2008; 283:28274-28286. [PMID: 18682393].
26. Lin SL. Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation. Stem Cells 2011; 2 9:1645-1649. [PMID: 21948625].
27. Kutty RK, Samuel W, Jaworski C, Duncan T, Nagineni CN, Raghavachari N, Wiggert B, Redmond TM. MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: increased expression of microRNA-9 by N-(4-hydroxyphenyl)retinamide. Mol Vis 2010; 16:1475-1486. [PMID: 20806079].
28. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 2009; 47:5-14. [PMID: 19336275].
29. Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev 2011; 25:1734-1745. [PMID: 218169 2 2].
30. Zhang X, Chen LX, Ouyang L, Cheng Y, Liu B. Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. Cell Prolif 2012; 45:466-476. [PMID: 22765290].
31. Recio MC, Andujar I, Rios JL. Anti-inflammatory agents from plants: progress and potential. Curr Med Chem 2012; 19:2088-2103. [PMID: 2 2 414101].
32. Vinod BS, Maliekal TT, Anto RJ. Phytochemicals As Chemo-sensitizers: From Molecular Mechanism to Clinical Significance. Antioxid Redox Signal 2012; 9:9[PMID: 22871022].
33. King RE, Kent KD, Bomser JA. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem Biol Interact 2005; 151:143-149. [PMID: 15698585].
34. Pintea A, Rugina D, Pop R, Bunea A, Socaciu C, Diehl HA. Antioxidant effect of trans-resveratrol in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther 2011; 2 7: 315-321. [PMID: 21663493].
35. Lançon A, Kaminski J, Tili E, Michaille JJ, Latruffe N. Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem 2012; 60:8783-8789. [PMID: 2 2 571175].
36. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22:1-29. [PMID: 12597922].
37. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11:228-234. [PMID: 19255566].
38. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704-114. [PMID: 19 7 6 3153].
39. Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2011; 52:4402-4409. [PMID: 2149 8 619].
40. Suárez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008; 105:14082-14087. [PMID: 18779589].
41. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 2006; 1:e116[PMID: 17205120].
42. Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF, Campochiaro PA. MicroRNAs regulate ocular neovascularization. Mol Ther 2008; 16:1208-1216. [PMID: 1850 0 2 51].
43. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006; 281:18277-18284. [PMID: 16675453].
44. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S. Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci USA 2011; 108:8287-8292. [PMID: 21536891].
45. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008; 269:199-225. [PMID: 184798 0 7].
46. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595:1-75. [PMID: 17569205].
47. Pendurthi UR, Rao LV. Suppression of transcription factor Egr-1 by curcumin. Thromb Res 2000; 97:179-189. [PMID: 10674404].
48. Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) J Biol Chem 1995; 270:24995-25000. corrected[PMID: 7559628].
49. Cho JW, Lee KS, Kim CW. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 2007; 19:469-474. [PMID: 17273796].
50. Singh S, Khar A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 2006; 6:259-270. [PMID: 16712454].
51. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloyl-methane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003; 171:3863-3871. [PMID: 1450 0 688].
52. Chen YR, Tan TH. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998; 17:17-38[PMID: 9 6 74 7 01].
53. Weir NM, Selvendiran K, Kutala VK, Tong L, Vishwanath S, Rajaram M, Tridandapani S, Anant S, Kuppusamy P. Curcumin induces G2/M arrest and apoptosis in cisplatinresistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 2007; 6:178-184. [PMID: 17 218 7 8 3].
54. Wang S, Yu S, Shi W, Ge L, Yu X, Fan J, Zhang J. Curcumin Inhibits the Migration and Invasion of Mouse Hepatoma Hca-F Cells Through Down-regulating Caveolin-1 Expression and Epidermal Growth Factor Receptor Signaling. IUBMB Life 2011; 63:775-782. [PMID: 22362715].
55. Camacho-Barquero L, Villegas I, Sanchez-Calvo JM, Talero E, Sanchez-Fidalgo S, Motilva V, Alarcon de la Lastra C. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 2007; 7:333-342. [PMID: 172768 91].
56. Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan A P, Arumugam S, Suzuki K. Curcumin attenuates diabetic nephropathy by inhibiting PKC-alpha and PKC-beta1 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res 2011; 55:1655-1665. [PMID: 22045654].
57. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 2007; 67:3853-3861. [PMID: 17440100].
58. Lin J, Chen A. Activation of peroxisome proliferator-activatedreceptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest 2008; 88:529-540. [PMID: 18332 8 71].
59. Arbiser JL, Klauber N, Rohan R, van Leeuwen R, Huang MT, Fisher C, Flynn E, Byers HR. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 1998; 4:376-83. [PMID: 10780880].
60. Gururaj AE, Belakavadi M, Venkatesh DA, Marme D, Salimath BP. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 2002; 297:93442. [PMID: 12359244].
61. Anand P, Sung B, Kunnumakkara AB, Rajasekharan KN, Aggarwal BB. Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors. Biochem Pharmacol 2011; 82:1901-1909. [PMID: 21924245].